| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.7 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |